P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients

BACKGROUND: Among primary brain tumors, glioblastoma (GBM) is the most common and aggressive in adults, with limited treatment options. Our previous study showed that autologous formalin-fixed tumor vaccine (AFTV) contributed to prognostic improvements in newly diagnosed GBM patients. However, some...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Erika, Ishikawa, Eiichi, Miyazaki, Tsubasa, Miki, Shunichiro, Sugii, Narushi, Kohzuki, Hidehiro, Tsurubuchi, Takao, Sakamoto, Noriaki, Watanabe, Shinya, Matsuda, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362834/
https://www.ncbi.nlm.nih.gov/pubmed/37484760
http://dx.doi.org/10.1093/noajnl/vdad079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362834/
https://www.ncbi.nlm.nih.gov/pubmed/37484760
http://dx.doi.org/10.1093/noajnl/vdad079

Ejemplares similares